Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Feb;97(2):e70197.
doi: 10.1002/jmv.70197.

Metabolic Reprogramming in Epstein-Barr Virus Associated Diseases

Tiffany Melanie Yee  1 , Liang Wei Wang  1
Affiliations
Review

Metabolic Reprogramming in Epstein-Barr Virus Associated Diseases

Tiffany Melanie Yee et al. J Med Virol. 2025 Feb.

Abstract

Epstein-Barr virus (EBV) is the first human cancer-causing viral pathogen to be discovered; it has been epidemiologically associated with a wide range of diseases, including cancers, autoimmunity, and hyperinflammatory disorders. Its evolutionary success is underpinned by coordinated expression of viral transcription factors (EBV nuclear antigens), signaling proteins (EBV latent membrane proteins), and noncoding RNAs, which orchestrate cell transformation, immune evasion, and dissemination. Each of those activities entails significant metabolic rewiring, which is achieved by viral subversion of key host metabolic regulators such as the mammalian target of rapamycin (mTOR), MYC, and hypoxia-inducible factor (HIF). In this review, we systemically discuss how EBV-encoded factors regulate metabolism to achieve viral persistence and propagation, as well as potential research questions and directions in EBV-driven metabolism.

Keywords: EBV; Epstein–Barr virus; metabolism; oncometabolism; virus‐driven metabolism.

PubMed Disclaimer

References

    1. M. A. Epstein, B. G. Achong, and Y. M. Barr, “Virus Particles in Cultured Lymphoblasts From Burkitt's Lymphoma,” Lancet 283, no. 7335 (March 1964): 702–703.
    1. M. A. Epstein, G. Henle, B. G. Achong, and Y. M. Barr, “Morphological and Biological Studies on a Virus in Cultured Lymphoblasts From Burkitt's Lymphoma,” Journal of Experimental Medicine 121, no. 5 (May 1965): 761–770.
    1. M. A. Epstein, Y. M. Barr, and B. G. Achong, “The Behaviour and Morphology of a Second Tissue Culture Strain (EB2) of Lymphoblasts From Burkitt's Lymphoma,” British Journal of Cancer 19, no. 1 (March 1965): 108–115.
    1. N. Y. T. Leung and L. W. Wang, “Targeting Metabolic Vulnerabilities in Epstein–Barr Virus‐Driven Proliferative Diseases,” Cancers 15, no. 13 (2023): 3412.
    1. O. Gires, “Latent Membrane Protein 1 of Epstein‐Barr Virus Mimics a Constitutively Active Receptor Molecule,” EMBO Journal 16, no. 20 (October 1997): 6131–6140, https://doi.org/10.1093/emboj/16.20.6131.

MeSH terms

Substances

LinkOut - more resources